导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.96% | 728/1050 |
| 近一周 | -4.26% | 1010/1104 |
| 近一月 | -1.97% | 221/1102 |
| 近一季 | -5.33% | 432/1092 |
| 近半年 | -17.62% | 947/1070 |
| 近一年 | 20.75% | 229/1018 |
| 近两年 | 85.16% | 250/926 |
| 近三年 | 71.06% | 144/834 |
| 成立以来 | 378.58% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.56% 291/1070 |
-15.78% 1032/1101 |
- - |
- - |
| 2025 | 86.72% 26/1065 |
7.40% 258/1014 |
4.89% 307/1038 |
40.44% 185/1050 |
18.02% 12/1065 |
| 2024 | 2.81% 506/1011 |
12.96% 11/960 |
1.68% 209/983 |
4.56% 896/991 |
-14.40% 978/1011 |
| 2023 | -0.40% 106/952 |
6.09% 249/880 |
-6.78% 627/895 |
3.11% 17/915 |
-2.33% 258/952 |
| 2022 | -11.85% 112/867 |
2.34% 2/773 |
2.29% 658/806 |
-8.27% 156/845 |
-8.21% 740/867 |
| 2021 | 22.67% 138/740 |
0.50% 132/580 |
10.25% 349/659 |
17.27% 23/704 |
-5.59% 607/740 |
| 2020 | 88.24% 65/554 |
-7.87% 353/419 |
16.33% 331/466 |
29.83% 7/517 |
35.28% 23/554 |
| 2019 | 33.78% 269/410 |
13.29% 1027/1146 |
0.21% 309/1228 |
1.38% 296/390 |
16.24% 35/410 |
| 2018 | -34.23% 263/349 |
- - |
-9.19% 439/990 |
-4.98% 456/1000 |
-16.40% 937/1080 |
| 2017 | 26.76% 55/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 创金合信资源股票发起式A VS. 东吴新产业精选股票A(580008) |